Computerized innovations take top spot in European patent applications

Wednesday, April 22, 2020memonhusenSource: IIPLA
Computerized innovations take top spot in European patent applications
Source attribution
Image: Image courtesy of iipla.org

Computerized innovations take top spot in European patent applications 

Patent insights distributed today by the European Patent Office (EPO) show that without precedent for over ten years. Computerized advancements have started to lead the pack in patent applications documented. As indicated by the EPO Patent Index 2019, the flood in the fields of electronic correspondence (+19.6%) and PC innovation (+10.2%) is fuelling the continued development in patent filings. In 2019, the EPO got well more than 181 000 applications altogether, 4% more than in 2018.

"The quick ascent of computerized advances is the most striking pattern from our 2019 list," said EPO President António Campinos. Computerized change of the economy presently reflects in the patent applications. With our settled and all-inclusive perceived way to deal with looking at applications in the advanced field. The EPO set to help innovators and cultivate development in Europe and the past. Significantly, organizations and scientists in Europe are looking to ensure their developments locate a level playing field with their rivals from Asia and the US and can keep up a solid situation in the global innovation advertise."

5G and AI as drivers of development 

Among the top specialized fields at the EPO, advanced correspondence and PC innovation saw the steepest development. Featuring their crucial job in driving the computerized change that is penetrating all parts and ventures. Patent applications in advanced correspondence developed by +19.6% in 2019, surpassing clinical innovation (+0.9%). Wherein It had been the most patent-dynamic innovation since 2006. This field, incorporates advances that are significant to actualizing 5G remote systems.

With an expansion of 64.6%, Chinese organizations contributed most to the development in advanced correspondence patent applications, with US (+14.6%) and South Korean firms (+36.1%, though from a littler base) taking action accordingly. By examination, filings from Europe developed modestly (+3.1%). As far as an offer, China, the US, and Europe are currently the joint chiefs, each representing about a fourth of every single patent application documented with the EPO in this field. The primary three candidates in 2019 were Huawei, Ericsson, and Qualcomm.

The second quickest developing field at the EPO in 2019 was PC innovation (+10.2%). Here the driving component for development was the expansion in patent applications identified with human-made reasoning, particularly in the regions of AI and example acknowledgment, picture information handling and age, and information recovery.

US organizations (+13.6% more than 2018) represented about 40% of every single patent application in PC innovation, trailed by EPO part states (+9.3%) with practically 30% of the aggregate. Applications from China (+18.7%) made up only over 10%. The primary candidates in 2019 were Alphabet (Google), Microsoft, Samsung, Huawei, Intel, and Siemens (Fig.: Leading candidates, PC innovation). The vast extent of the development in 2019 additionally originated from littler candidates and new players.

Related Coverage

Continue in the newsroom

Back to newsroom
IP News

Purple Rain Co-Star Ends Apollonia Trademark Rights Suit

‘Purple Rain’ Co-Star Ends ‘Apollonia’ Trademark Rights Suit By Editorial Team Patty Apollonia Kotero, known for her role as Prince’s co-star in the iconic 1984 film “Purple Rain,” has decided to drop her lawsuit agai...

Thursday, April 9, 2026
IP News

Federal Circuit Grills Sanctioned Patent Lawyer Over Conduct

Federal Circuit Grills Sanctioned Patent Lawyer Over Conduct By Editorial Team A Houston-based patent attorney faced a tough Federal Circuit bench while seeking to wipe out a $207,000 sanction against him and his clie...

Thursday, April 9, 2026
IP News

J&J Defends Blood-Clotting Powder IP From Baxter Attack

J&J Defends Blood-Clotting Powder IP From Baxter Attack By Editorial Team A subsidiary of Johnson & Johnson has successfully defended its patent for a hemostatic powder used to treat bleeding against objections from B...

Thursday, April 9, 2026